Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement (TIMI)

This study has been completed.
Sponsor:
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01176110
First received: July 29, 2010
Last updated: May 18, 2011
Last verified: July 2010

July 29, 2010
May 18, 2011
July 2010
March 2011   (final data collection date for primary outcome measure)
Temperature at the end of the intervention [ Time Frame: average 2 hours ] [ Designated as safety issue: Yes ]
The end of the surgical procedure is defined and is recorded for all patients in the hospital information systems. This time point will be used to record the body temperature at the end of the intervention
Same as current
Complete list of historical versions of study NCT01176110 on ClinicalTrials.gov Archive Site
  • hospital stay [ Time Frame: max 28 days ] [ Designated as safety issue: No ]
  • mechanical ventilation time [ Time Frame: maximum 28 days ] [ Designated as safety issue: No ]
    The mechanical ventilation time in the hospital is recorded electronically. The time frame will be recorded as the outcome measure in this study.
Same as current
Not Provided
Not Provided
 
Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement
A Randomized Pilot Study for Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement

It is known that perioperative hypothermia can influence the postoperative outcome negatively.

The most important complications are cardiac, increased blood loss with need for transfusion and a significantly increased wound infection rate.

The thermal redistribution after the induction of anesthesia is on of the reasons for perioperative hypothermia. Another reason is negative heat balance during surgery.

Further negative side effects of hypothermia are an increase of blood viscosity and thus a higher risk for thrombosis, coagulopathy and thus an increased risk of bleeding.

The aim of the study is to evaluate if patients with a perioperative active thermal management during an interventional minimal invasive valve replacement have a significantly higher body temperature at the end of the operation than patients without an active thermal management. Secondary outcome variables are complication rates, length of mechanical ventilation and length of ICU treatment.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
  • Outcomes
  • Body Temperature
Device: LMA Perfect Temp
The LMA PerfecTemp™ patient warming system combines warming beneath the patient and advanced pressure reduction to combat hypothermia and decubitus ulcers. This device is used during the interventional minimal invasive valve replacement with unprecedented ease and safety
  • Experimental: thermal management with LMA PerfecTemp™
    Intervention: Device: LMA Perfect Temp
  • Active Comparator: no specific thermal management
    Intervention: Device: LMA Perfect Temp
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
May 2011
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients, who need an interventional minimal invasive valve replacement
  • Age ≥ 18 years
  • scheduled general anesthesia during intervention
  • no participation on another interventional study
  • signed informed consent

Exclusion Criteria:

  • pregnant or breast feeding women
  • non-elective intervention
  • conversion to HLM
  • implantation of IABP
  • pre-existing decubitus
  • patients who are not able to sign informed consent
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01176110
TIMI101, EA1/142/10
Yes
PD Dr. Michael Sander, Department of Anesthesiology and Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum Charité - Universitätsmedizin Berlin
Charite University, Berlin, Germany
Not Provided
Principal Investigator: Michael Sander, MD Dept. of Anesthesiology Charité Universitaetsmedizin Berlin
Study Chair: Claudia Spies, MD Dept. of Anesthesiology Charité Universitaetsmedizin Berlin
Charite University, Berlin, Germany
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP